Psoriasis: Update in Oral and Biologic Therapy

This session offers a roadmap to pharmacologic care in psoriatic arthritis (PsA). APPs will learn to navigate when to use DMARDs, biologics, or JAK inhibitors based on disease phenotype. Faculty will emphasize treatment sequencing, safety, and special considerations for patients with IBD or uveitis. Strategies for tapering therapy during remission will also be reviewed.